Medicare Enrolled

Dr. Chia-Wen Hsu, M.D.

Gastroenterology · Austin, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Mixed engagement
4310 JAMES CASEY ST, Austin, TX 78745
5124484588
In practice since 2005 (20 years)
NPI: 1568447670 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hsu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hsu? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hsu

Dr. Chia-Wen Hsu is a gastroenterology in Austin, TX, with 20 years in practice. Based on federal Medicare data, Dr. Hsu performed 946 Medicare services across 914 unique beneficiaries.

Between the years covered by Open Payments, Dr. Hsu received a total of $28,153 from 42 pharmaceutical and/or device companies across 917 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hsu is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 27% volume in TX$ $28,153 industry payments

Medicare Practice Summary

Medicare Utilization ↗
946
Medicare services
Top 27% in TX for gastroenterology
914
Unique beneficiaries
$116
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~47 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Removal of polyps or growths of large bowel using an endoscope with mechanical snare185$183$1,171
Office visit, established patient (20-29 min)132$65$160
Office visit, established patient (30-39 min)131$87$234
Colonoscopy with biopsy93$92$883
Upper GI endoscopy with biopsy85$65$592
New patient office visit (30-44 min)63$61$235
Colorectal cancer screening; colonoscopy on individual at high risk48$179$803
Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope43$66$575
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk32$177$818
New patient office visit (45-59 min)31$117$365
Study of esophagus to assess movement30$181$882
Diagnostic exam of large bowel using a flexible endoscope23$134$818
Prolonged monitoring and recording of esophageal function through nasal tube with electrode17$335$921
New patient office or other outpatient visit, 15-29 minutes17$44$165
Monitoring and recording of esophageal function through nasal tube with electrode16$139$310
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$28,153
Total received (2018-2024)
Avg $4,022/year across 7 years
Top 9% in TX for gastroenterology
42
Companies
917
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,799 (45.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12,420 (44.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,935 (10.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,773
2023
$2,173
2022
$1,864
2021
$2,112
2020
$1,362
2019
$3,475
2018
$15,394

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$7,874
Allergan Inc.
$6,374
Gilead Sciences, Inc.
$3,539
ABBVIE INC.
$2,061
AbbVie Inc.
$1,373
Celgene Corporation
$1,041
AbbVie, Inc.
$973
Janssen Scientific Affairs, LLC
$809
PFIZER INC.
$585
Janssen Biotech, Inc.
$574
Takeda Pharmaceuticals U.S.A., Inc.
$505
Romark Laboratories, LC
$346
Ironwood Pharmaceuticals, Inc
$296
GENZYME CORPORATION
$252
Daiichi Sankyo Inc.
$248
RedHill Biopharma Inc.
$186
NESTLE HEALTHCARE NUTRITION INC.
$115
Madrigal Pharmaceuticals
$113
Merck Sharp & Dohme LLC
$89
Intercept Pharmaceuticals, Inc.
$66
Nestle HealthCare Nutrition Inc.
$64
Braintree Laboratories, Inc.
$60
BOSTON SCIENTIFIC CORPORATION
$58
Shionogi Inc
$58
INTERCEPT PHARMACEUTICALS, INC.
$57
Lilly USA, LLC
$52
AIMMUNE THERAPEUTICS, INC.
$52
Celltrion USA Inc.
$48
Synergy Pharmaceuticals Inc
$31
UCB, Inc.
$31
Ipsen Biopharmaceuticals, Inc
$27
QOL Medical, LLC
$26
Regeneron Healthcare Solutions, Inc.
$26
Johnson & Johnson Health Care Systems Inc.
$21
Boston Scientific Corporation
$19
Phathom Pharmaceuticals, Inc.
$18
Concordia Pharmaceuticals Inc.
$17
Prometheus Laboratories Inc.
$15
E.R. Squibb & Sons, L.L.C.
$15
IRONWOOD PHARMACEUTICALS, INC
$15
Dova Pharmaceuticals
$13
Endo Pharmaceuticals Inc.
$13
Top 3 companies account for 63.2% of total payments
Associated products mentioned in payments ›
ALINIA · APRISO · Aemcolo · Alinia · Alinia Tablets 500mg 30 count bottle · Amitiza · CREON · Cimzia · Creon · DIFICID · DUPIXENT · Dexilant · Donnatal · Doptelet · ENTYVIO · Entyvio · GATTEX · General - Polypectomy · HUMIRA · Humira · INFLECTRA · INJECTAFER · IQIRVO · LINZESS · Linzess · MAVYRET · MOTEGRITY · MOTOFEN · Mavyret · Movantik · NASCOBAL · OCALIVA · OMVOH · REMICADE · RESMETIROM · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUPREP BOWEL PREP · SUTAB · Symproic · TRULANCE · Talicia · Trulance · VEGZELMA · VELSIPITY · VIBERZI · VOQUEZNA · VOWST · Vemlidy · WATCHMAN · XELJANZ · XIFAXAN · XIFAXANIBSD · YUFLYMA · ZENPEP · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (46%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for gastroenterology in TX.

Equivalent to $2,976 per 100 Medicare services performed
Looking for a gastroenterology in Austin?
Compare gastroenterologys in the Austin area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologys nearby

Geographic Context

Gastroenterologys within 10 mi
67
Per 100K population
5.1
County median income
$97,169
Nearest hospital
AUSTIN OAKS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Hsu is a clinical cardiology specialist, with above-average Medicare volume (top 27% in TX), and high industry engagement (mixed engagement, top 9%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Hsu experienced with removal of polyps or growths of large bowel using an endoscope with mechanical snare?
Based on Medicare claims data, Dr. Hsu performed 185 removal of polyps or growths of large bowel using an endoscope with mechanical snare services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hsu receive payments from pharmaceutical companies?
Yes. Dr. Hsu received a total of $28,153 from 42 companies across 917 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hsu's costs compare to other gastroenterologys in Austin?
Dr. Hsu's average Medicare payment per service is $116. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hsu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →